信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·先达股份:全资子公司投资建设年产1800吨农药原药、年产500吨安全剂项目2023-12-4 17:09:57
·海思科:获得创新药HSK36357胶囊《药物临床试验批准通知书》2023-12-4 16:27:32
·医药生物行业周报:第四批耗材国采拟中选结果公布,关注国产替代发展机会2023-12-4 15:26:03
·医药生物行业周报:如何寻找增长的确定性2023-12-4 14:24:56
·美容护理行业周报:华东医药自研减肥药获新进展,短剧赋能美妆营销2023-12-4 13:55:25
·药明生物:公司股份已暂停买卖,以待刊发可能构成公司内幕消息的公告2023-12-4 13:30:17
·医药行业周报:医药震荡行情,散点开花2023-12-4 12:19:30
·违规减持迎重拳,这家医药股遭证监会立案!世界级智能制造大会即将召开,这些业绩高增长潜力概念股值得关注2023-12-4 9:49:07
·一品红:获得非诺贝特酸胆碱缓释胶囊药品补充申请批准通知书2023-12-3 19:34:50
·医药生物行业跟踪周报:器械集采利空出清,龙头份额有望提升2023-12-3 19:22:30
·21股获买入评级 最新:康缘药业 2023-12-3 19:01:47
·16股获买入评级 最新:济川药业 2023-12-3 18:41:28
·恒瑞医药:SHR0302片药物上市许可申请获国家药监局受理2023-12-3 18:20:13
·近18万人参与!走进多肽龙头翰宇药业:国际化将迎收获期2023-12-3 18:07:40
·一品红加大创新药研发投入 构建多样化产品管线2023-12-2 12:34:42
·IgA肾病新药获批上市 云顶新耀预计2025年可实现“现金流打平”2023-12-2 11:35:49
·《新时代中医药标志性科技成果(2012-2022)》发布2023-12-2 10:49:12
·奥翔药业(603229)12月1日主力资金净卖出128.06万元2023-12-2 10:20:16
·太龙药业(600222)12月1日主力资金净卖出1072.39万元2023-12-2 10:07:35
·国产创新药出海喜报频传 行业加速进入盈利兑现黄金期2023-12-2 9:58:41

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]